Previous 10 | Next 10 |
Shares of PerkinElmer Inc. (NYSE:PKI) traded at a new 52-week high today of $188.40. This new high was reached on below average trading volume as 237,000 shares traded hands, while the average 30-day volume is approximately 810,000 shares. PerkinElmer Inc. (NYSE:PKI) is currently priced ...
PerkinElmer Inc. (NYSE:PKI) traded today at a new 52-week high of $187.14. So far today approximately 232,000 shares have been exchanged, as compared to an average 30-day volume of 788,000 shares. PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceut...
PerkinElmer Inc. (NYSE:PKI) traded today at a new 52-week high of $185.68. So far today approximately 406,000 shares have been exchanged, as compared to an average 30-day volume of 779,000 shares. In the past 52 weeks, PerkinElmer Inc. share prices are bracketed by a low of $111.45 and a...
The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: PerkinElmer, Inc. 2021 Q2 - Results - Earnings Call Presentation
PerkinElmer (NYSE:PKI): Q2 Non-GAAP EPS of $2.83 beats by $1.14; GAAP EPS of $2.19 beats by $0.99. Revenue of $1.3B (+60.1% Y/Y) beats by $290M. Press Release For further details see: PerkinElmer EPS beats by $1.14, beats on revenue
Shares of PerkinElmer Inc. (NYSE:PKI) traded at a new 52-week high today of $183.85. Approximately 696,000 shares have changed hands today, as compared to an average 30-day volume of 762,000 shares. Over the past year, PerkinElmer Inc. has traded in a range of $111.45 to $183.85 and is n...
Image source: The Motley Fool. PerkinElmer, inc (NYSE: PKI) Q2 2021 Earnings Call Jul 28, 2021 , 7:00 p.m. ET Operator Continue reading For further details see: PerkinElmer, inc (PKI) Q2 2021 Earnings Call Transcript
PerkinElmer, Inc. (PKI) Q2 2021 Earnings Conference Call July 26, 2021, 08:00 AM ET Company Participants Steven Willoughby - VP of IR Prahlad Singh - President and CEO Jamey Mock - SVP and CFO Gene Lay - Founder and CEO, BioLegend PerkinElmer, Inc. Craig Monell - Head, Product Strategy & ...
PerkinElmer has used the current pandemic boom to pursue multiple bolt-on deals. These multiple deals are accompanied by a huge deal as well, something liked by investors. I like the potential of the business in the long haul, yet the big move in the shares in recent months makes ...
PerkinElmer Inc. (NYSE:PKI) traded today at a new 52-week high of $169.11. This new high was reached on approximately average trading volume as 499,000 shares traded hands, while the average 30-day volume is approximately 664,000 shares. PerkinElmer provides instruments, tests, services,...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...